Menu
OR
OR
Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients

Hematology

...
HemaSphere, Volume 9, Issue 3, March 2025.

Read Full Article

Journal Source :

HemaSphere

© 2024 Imedsource, All Rights Reserved

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.